Aim of the Journal

The aim of the journal is to advance clinical research and medical innovation by publishing impactful studies that enhance the design, conduct, analysis, and reporting of clinical trials across all areas of medicine.

The scope of the journal includes, but is not limited to:

• Clinical Trial Design and Methodology
• Phase I–IV Clinical Trials
• Randomized Controlled Trials (RCTs)
• Drug Development and Therapeutic Evaluation
• Pharmacokinetics and Pharmacodynamics
• Biostatistics and Clinical Data Analysis
• Evidence-Based Medicine
• Medical Device Trials
• Vaccine and Immunotherapy Trials
• Oncology Clinical Trials
• Cardiovascular and Metabolic Trials
• Neurological and Psychiatric Trials
• Rare Disease and Orphan Drug Studies
• Real-World Evidence and Observational Studies
• Regulatory Affairs and Clinical Ethics
• Pharmacovigilance and Drug Safety
• Personalized and Precision Medicine Trials
• Digital Health and AI in Clinical Research
• Translational and Experimental Clinical Studies
• Innovations in Healthcare Research Methodology